Weekly CEO Sells Highlight: Globus Medical Inc, Diplomat Pharmacy Inc, Zendesk Inc, and Amicus Therapeutics Inc.

Author's Avatar
Mar 28, 2015

According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Globus Medical Inc, Diplomat Pharmacy Inc, Zendesk Inc, and Amicus Therapeutics Inc.

Globus Medical Inc (GMED, Financial): CEO, 10% Owner David C Paul sold 1,922,000 Shares

CEO, 10% Owner of Globus Medical Inc (GMED, Financial) David C Paul sold 1,922,000 shares on 03/19/2015 at an average price of $25. Globus Medical Inc was incorporated in Delaware in March 3, 2003. Globus Medical Inc has a market cap of $2.33 billion; its shares were traded at around $24.58 with a P/E ratio of 25.20 and P/S ratio of 4.95.

Globus Medical Inc. reported their 2014 annual results. The Company announced sales of $474.4 million and net income of $92.5 million.

CEO, 10% Owner David C Paul sold 1,922,000 shares of GMED stock on 03/19/2015 at the average price of 25. President and COO David M Demski and Senior VP, Operations David D Davidar together sold 71,010 shares of GMED stock in October and February.

Diplomat Pharmacy Inc (DPLO, Financial): Chairman and CEO, 10% Owner Philip R Hagerman sold 1,801,000 Shares

Chairman and CEO, 10% Owner of Diplomat Pharmacy Inc (DPLO, Financial) Philip R Hagerman sold 1,801,000 shares on 03/25/2015 at an average price of $29. Diplomat Pharmacy Inc was founded in 1975. The Company is a specialty pharmacy company engaged in improving the lives of patients with complex chronic diseases. Diplomat Pharmacy Inc has a market cap of $1.74 billion; its shares were traded at around $33.72 with a P/E ratio of 571.70 and P/S ratio of 0.59.

Diplomat Pharmacy Inc. recognized revenues of $2.2 billion and net income of $4.3 million in its 2014 full year results.

Chairman and CEO, 10% Owner Philip R Hagerman sold 8,509,333 shares of DPLO stock in October and March. CFO Sean Whelan bought 2,000 shares of DPLO stock on 10/09/2014 at the average price of 13. Director David C Dreyer and SVP of Sales & Business Dev Atheer A Kaddis together bought 5,034 shares of DPLO stock in October and March. EVP of Operations Jeffrey M Rowe sold 600,000 shares of DPLO stock in March.

Zendesk Inc (ZEN, Financial): Chairman and CEO Mikkel Svane sold 600,000 Shares

Chairman and CEO of Zendesk Inc (ZEN, Financial) Mikkel Svane sold 600,000 shares on 03/24/2015 at an average price of $21.76. Zendesk Incw was incorporated in Delaware in April 2009. Zendesk Inc has a market cap of $1.68 billion; its shares were traded at around $22.22 with and P/S ratio of 9.37.

Zendesk Inc. announced its 2014 fourth quarter financial results with revenues of $38.5 million and net loss of $17.5 million.

Chairman and CEO Mikkel Svane sold 600,000 shares of ZEN stock on 03/24/2015 at the average price of 21.76. SVP and CFO Alan J Black sold 40,000 shares of ZEN stock in February and March. SVP Operations Anne Raimondi, Director, 10% Owner Devdutt Yellurkar, and SVP of Product Development Adrian Mcdermott together sold 437,294 shares of ZEN stock in March.

Amicus Therapeutics Inc (FOLD, Financial): Chairman & CEO John F Crowley sold 268,322 Shares

Chairman & CEO of Amicus Therapeutics Inc (FOLD, Financial) John F Crowley sold 268,322 shares on 03/20/2015 at an average price of $11.49. Amicus Therapeutics Inc incorporated under the laws of the State of Delaware on February 4, 2002. Amicus Therapeutics Inc has a market cap of $1.05 billion; its shares were traded at around $10.96 with and P/S ratio of 666.59. Amicus Therapeutics Inc had an annual average earnings growth of 20.10% over the past 5 years.

Amicus Therapeutics Inc. declared its 2014 annual results, which included revenues of $1.2 million and net loss of $68.9 million.

Chairman & CEO John F Crowley sold 357,322 shares of FOLD stock in December and March. CFO William D Baird III sold 35,235 shares of FOLD stock in October, November, and March. VP Clinical Ops & Data Mgmt Julie Yu, VP, Pharmacology & Biology Ken Valenzano, VP, Legal & IP Kenneth Peist, and VP, Regulatory Affairs John Kirk together sold 40,945 shares of FOLD stock in March.

For the complete list of stocks that bought by their CEOs, go to: Insider Buys.